Breakthrough pancreatic cancer drug that DOUBLES survival gets FDA approval - Daily Mail
Breakthrough pancreatic cancer drug that DOUBLES survival gets FDA approval Daily Mail
The health section covers stories about medical progress, recovery, and wellbeing. We look for genuine advances: new therapies clearing regulatory hurdles, diseases being eradicated in specific regions, communities improving public health outcomes through evidence-based programs. Celebrity wellness trends and supplement marketing do not make the cut.
The morning letter delivers the day's best positive headlines before the rest of the internet gets loud. Free, no tracking, one click to leave.
Get the morning letter →
A team looked at 80 major trials involving nearly 30,000 people and found that nicotine vapes were more effective than t…
US FDA approves updated COVID vaccines for 2026-27 season Reuters
Scientists created smart nanoparticles that can both illuminate hidden glioblastoma cells during surgery and destroy mic…
As multidrug antibiotic resistance emerges as a potent public health challenge, medical science has renewed attention on…
Most news feeds won't give you another one. Our morning letter will: one email at sunrise with the day's best good news.
Start tomorrow morning →